PTEN and PDCD4 are Bona Fide Targets of microRNA-21 in Human Cholangiocarcinoma


Chang-zheng Liu 1 , Wei Liu 2 , Yi Zheng 2 , Jin-mei Su 3 , Jing-jing Li 2 , Lan Yu 2 , Xiao-dong He 2 , and Song-sen Chen 1 1 Department of Biochemistry, National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China 2 Department of General Surgery, 3 Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China


Objective To investigate the expression profile of microRNA-21 in human cholangiocarcinoma tissues and to validate its bona fide targets in human cholangiocarcinoma cells. Methods The expression profile of microRNA-21 in human cholangiocarcinoma tissues and cholangiocarcinoma cell line, QBC939, was evaluated by using real-time PCR analysis. The bona fide targets of microRNA-21 were analyzed and confirmed by dual luciferase reporter gene assay and western blot, respectively. The expressional correlation of microRNA-21 and its targets was probed in human cholangiocarcinoma tissues by using real-time PCR, locked nucleic acid in situ hybridization (LNA-ISH), and immunohistochemistry analysis. Results Real-time PCR analysis revealed that microRNA-21 expression depicted a significant up-regulation in human cholangiocarcinoma tissues about 5.6-fold as compared to the matched normal bileduct tissues (P<0.05). The dual luciferase reporter gene assay revealed endogenous microRNA-21 in cholangiocarcinoma cell line, QBC939, inhibited the luciferase reporter activities of wild-type PTEN (P<0.01) and PDCD4 (P<0.05) and had no this effect on mutated PTEN and PDCD4. Moreover, loss of microRNA-21 function led to a significant increase of PTEN and PDCD4 protein levels in QBC939 cells. Elevated microRNA-21 levels were accompanied by marked reductions of PTEN and PDCD4 expression in the same cholangiocarcinoma tissue. Conclusion microRNA-21 expression is up-regulated in human cholangiocarcinoma and PTEN, PDCD4 are direct effectors of microRNA-21.


cholangiocarcinoma; microRNA-21; phosphatase and tensin homolog; programmed cell death 4


To explore the background and basis of the node document

Springer Journals Database

Total: 26 articles

  • [1] Fanyin Meng;;Roger Henson;;Hania Wehbe–Janek;;Kalpana Ghoshal;;Samson T. Jacob;;Tushar Patel, MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer, Gastroenterology,
  • [2] Changzheng Liu;;Jia Yu;;Shuangni Yu;;Robert M. Lavker;;Lei Cai;;Wei Liu;;Kegong Yang;;Xiaodong He;;Songsen Chen, MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma, Journal of Hepatology,
  • [3] Florin M. Selaru;;Alexandru V. Olaru;;Takatsugu Kan;;Stefan David;;Yulan Cheng;;Yuriko Mori;;Jian Yang;;Bogdan Paun;;Zhe Jin;;Rachana Agarwal;;James P. Hamilton;;John Abraham;;Christos Georgiades;;Hector Alvarez;;Perumal Vivekanandan;;Wayne Yu;;Anirban Maitra;;Michael Torbenson;;Paul J. Thuluvath;;Gregory J. Gores;;Nicholas F. LaRusso;;Ralph Hruban;;Stephen J. Meltzer, MicroRNA‐21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3, Hepatology,
  • [4] Justin L. Mott, MicroRNAs involved in tumor suppressor and oncogene pathways: Implications for hepatobiliary neoplasia, Hepatology,


Similar documents

Documents that have the similar content to the node document

Springer Journals Database

Total: 33 articles